Practice Management

More heart patients are opting to spend their final days at home rather than in the hospital or at a nursing facility, researchers reported in the latest edition of the Journal of the American College of Cardiology.

Researchers are calling for better implementation of ICD therapy after an analysis of the Swedish HF Registry found the devices to be beneficial—but underused—among patients with HFrEF.

A cardiac electrophysiologist in Boise, Idaho, is the first woman in the world to complete 1,000 cardiac catheter ablations using the Stereotaxis Robotic Magnetic Navigation System.

Annual hospital PCI-related mortality rates might be unreliable measures of a center’s performance, according to work published in JAMA Cardiology, proving unhelpful for identifying high-quality care in a study of 67 New York hospitals.

A 90-minute communication skills course improved conversations about ICD deactivation and goals of care between clinicians and their patients, according to the recently published results of the WISDOM study.

The ESC Digital Summit, Europe’s first-ever cardiac conference centered around digital health, is slated for Oct. 5 and 6 at the Creative Hub in Tallinn, Estonia, the European Society of Cardiology announced.

The American College of Cardiology on Sept. 16 issued its first-ever health policy statement on cardiologist compensation and opportunity equity, marking the first in a series of ACC workforce documents that will reportedly address workplace equality.

Women remain underrepresented in cardiology despite a growing pipeline of female medical students and internal medicine resident physicians, according to a Sept. 11 report in JAMA Cardiology.

Chicago biotech company BIOLIFE4D announced this week it had successfully 3D-bioprinted a mini human heart—something the company noted as a “significant milestone” on the path to printing full-sized hearts viable for transplant.

Proven protocols and practices, people and a push for earlier hemodynamic support are changing the face of cardiogenic shock survival. One leading health system has improved survival rates into the 70+ percent range. And their team believes other facilities should follow suit.

The level of pragmatism in CV-related randomized clinical trials has only increased moderately over the past two decades, according to work published in JAMA Cardiology Sept. 1.

Research presented this month at the ESC Congress in Paris suggests that getting a yearly influenza shot could greatly cut hypertensive patients’ risk of dying during flu season.